# A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

> **NCT05184829** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Progression
- Postoperative Recovery

## Interventions

- **OTHER:** selective lymph node dissection
- **OTHER:** Systemic Lymph Node Dissection

## Key facts

- **NCT ID:** NCT05184829
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05184829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05184829, "A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05184829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*